Search Result for 'glaucoma'

The Glaucoma Collaborative Care (GCC) clinic, delivered by The Royal Victorian Eye and Ear Hospital (Eye and Ear) and the Australian College of Optometry (ACO), is celebrating its 200th clinic this World ...

Specsavers has hit a major milestone in its efforts to find undetected glaucoma in Australia, ensuring patients now have more time and the opportunity to preserve their sight. Optometry provider Specsavers Australia ...

Glaucoma specialist and medical geneticist DR JANEY WIGGS revealed two new genes in juvenile early-onset glaucoma and dissected the value of polygenic risk scores when she delivered the Glaucoma Update Lecture at ...

With the average life expectancy at initial glaucoma diagnosis being up to 13 years, patients require a sustainable first line solution for a long-term condition. A study on selective laser trabeculoplasty (SLT) ...

At the completion of this article, the reader should be able to improve their glaucoma management. Including: Know how the classes of glaucoma medications induces/exacerbates Ocular surface disease (OSD) Recognise the symptoms ...

Glaukos has submitted a New Drug Application (NDA) to the US drug regulator – the FDA – for its iDose TR travoprost intraocular implant for glaucoma. The ophthalmic medical technology and pharmaceutical ...

Glaucoma is estimated to cost Australia $4.3 billion every year by 2025,¹ as a result of an ageing population. Approximately 10% of Australians over the age of 40 are considered to be ...

Glaukos announced positive results from a trial evaluating the safety of the surgical exchange procedure for its iDose TR (travoprost intraocular implant) for glaucoma. The ophthalmic medical technology and pharmaceutical company – ...

Five Australians are among an international team of scientists who have discovered a new gene mutation that may be a root cause of severe cases of childhood glaucoma. Through advanced genome-sequencing technology, ...

The landmark LiGHT (Laser in Glaucoma and Ocular Hypertension Trial) study – that ultimately recommended selective laser trabeculoplasty (SLT) as a first-line glaucoma intervention – has published six-year results demonstrating the longer ...